Live Chat

CFDs sind komplexe Instrumente und umfassen aufgrund der Hebelfinanzierung ein hohes Risiko, schnell Geld zu verlieren. 76,3% der Privatanlegerkonten verlieren Geld, wenn sie mit diesem Anbieter CFDs handeln. Sie sollten überlegen, ob Sie wirklich verstehen, wie CFDs funktionieren, und ob Sie es sich leisten können, das hohe Risiko von finanziellen Verlusten einzugehen.

Close

Bayer Live-Chart

Einsichten

Weekly Search
Weekly
Daily
date Schließen change Veränderung in % Eröffnen Hoch Niedrig

Markets.com news

French election results to drive European markets
markets.com Support Team 2024 Jul 04, 21:00

Wochenausblick: Französische Wahlergebnisse entscheidend für europäische Märkte

Forex Indizes
Macron calls snap election, riles markets
markets.com Support Team 2024 Jun 29, 21:00

Wochenausblick: Frankreich als Auslöser einer Euro-Krise?

CPI
Businessman pointing hologram online banking icon.
markets.com Support Team 2024 Jun 20, 16:00

Wochenausblick: Jede Menge Daten und Inflationseinblicke

Forex Indizes
RBA, SNB, Bank of England rate decisions due next week
markets.com Support Team 2024 Jun 13, 21:00

Wochenausblick: RBA, Bank of England im Stick-or-Twist-Modus

Forex Indizes

Info

Spread

0.13

Spread (%)

0.6778 %

Hebel

1:5

Übernacht-Zinsen (Kauf)

-0.0556 %

Übernacht-Zinsen (Verkauf)

-0.0333 %

Währung

EUR

Handelszeiten

Markets closed

Dienstag

08:02 - 11:59

Montag

08:02-11:59

Montag

12:04-16:29

Mittwoch

08:02-11:59

Mittwoch

12:04-16:29

Donnerstag

08:02-11:59

Donnerstag

12:04-16:29

Freitag

08:02-11:59

Freitag

12:04-16:29

Gewinn- und Verlustrechnung

Eröffnen

---

Vorher geschlossen

---

52-Wochen-Hoch/Tief

--- – ---

Marktkapitalisierung

18557988864

Ausstehende Aktien

982424000

Quartalsdatum (Nächstes)

2018-06-06

instr__dividend_date

instr__ex_dividend_date

2024-04-29

instr__forward_annual_dividend_rate

0.11

instr__forward_annual_dividend_yield

0.0058

EPS

-0.89

Ausstehende Aktien

Bayer Bayer AG NA
Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment provides breeding, propagation, and production/processing of seeds, including seed dressing. It has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases; and collaboration and license agreement with Cytokinetics for the development and commercialization of aficamten. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company was founded in 1863 and is headquartered in Leverkusen, Germany.

Erfahren Sie mehr über dieses Instrument

Basiswert
Verkaufen
Kaufen
Veränderung in %
Ähnliche Instrumente
Trustpilot
Live Chat